110546 ⎘
ssDNA viruses; Details; Parvoviridae; Dependovirus, e.g. adenoassociated viruses; Use of virus, viral particle or viral elements as a vector Special targeting system for viral vectors
CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#302Liver-specific constructs factor VIII expression cassettes and methods of use thereof
#303Selective recovery
#304Liver-specific constructs and methods of use thereof
#305CAPSID-MODIFIED RAAV VECTOR COMPOSITIONS AND METHODS THEREFOR
#306AAV HEPARIN MUTANTS THAT DISPLAY SIGNIFICANTLY IMPROVED EYE AND BRAIN TRANSDUCTION
#307DELIVERY OF CENTRAL NERVOUS SYSTEM TARGETING POLYNUCLEOTIDES
#308Capsid-modified rAAV vector compositions and methods therefor
#309Materials and methods for delivering nucleic acids to cochlear and vestibular cells
#310AAV's and uses thereof
#311Promoters and uses thereof
#312Prostate-targeting adeno-associated virus serotype vectors
#313Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
#314Chimeric adeno-associated virus/ bocavirus parvovirus vector
#315Viral vectors for the treatment of diabetes
#316Heterologous targeting peptide grafted AAVS
#317METHODS AND COMPOSITIONS RELATED TO ADENOASSOCIATED VIRUS-PHAGE PARTICLES
#318CAPSID-MODIFIED RAAV VECTOR COMPOSITIONS HAVING IMPROVED TRANSDUCTION EFFICIENCIES, AND METHODS OF USE
#319Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
#320Selective recovery
#321Capsid-modified, RAAV3 vector compositions and uses in gene therapy of human liver cancer
#322COMPOSITIONS AND METHODS FOR ACHIEVING HIGH LEVELS OF TRANSDUCTION IN HUMAN LIVER CELLS
#323Adeno-associated viruses engineered for selectable tropism
#324CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10)
#325CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#326Methods and compositions for treating genetic eye diseases
#327AAV vectors with high transduction efficiency and uses thereof for gene therapy
#328Mutated structural protein of a parvovirus
#329Compositions and methods for treating diseases
#330Capsid modified rAAV vectors and methods of use
#331Recombinant AAV variants and uses thereof
#332Methods and compositions for targeted gene transfer
#333AAV vectors targeted to the central nervous system
#334Class of therapeutic protein based molecules
#335CNS targeting AAV vectors and methods of use thereof
#336METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES
#337Methods and compositions for treating leber congenital amaurosis
#338High-transduction-efficiency rAAV vectors, compositions, and methods of use
#339AAV Vectors Targeted to Oligodendrocytes
#340Selective recovery
#341Telomerase reverse transcriptase-based therapies
#342CpG reduced factor VIII variants, compositions and methods and uses for treatment of hemostasis disorders
#343Selective recovery
#344Isolation of novel AAV's and uses thereof
#345Isolation of novel AAV's and uses thereof
#346Recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
#347Chimeric capsids
#348Humanized viral vectors and methods of use thereof
#349Liver-specific constructs, factor VIII expression cassettes and methods of use thereof
#350AAV vectors for retinal and CNS gene therapy
#351Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
#352Adeno-associated virus virions with variant capsid and methods of use thereof
#353METHODS AND COMPOSITIONS FOR GENE DELIVERY TO ON BIPOLAR CELLS
#354Adeno-associated virus virions with variant capsid and methods of use thereof
#355Adeno-associated virus virions with variant capsid and methods of use thereof
#356Compositions and methods for treating diseases
#357WIDESPREAD GENE DELIVERY OF GENE THERAPY VECTORS
#358GENE THERAPY COMPOSITIONS FOR USE IN THE PREVENTION AND/OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
#359Adeno-associated virus with site-directed mutagenesis and site-directed modification and preparation method and application thereof
#360AAV's and uses thereof
#361Class of therapeutic protein based molecules
#362Adeno-associated virus virions with variant capsid and methods of use thereof
#363Chimeric adeno-associated virus/ bocavirus parvovirus vector
#364CRISPR/CAS-related methods and compositions for treating leber's congenital amaurosis 10 (LCA10)
#365AAV vectors targeted to oligodendrocytes
#366Adeno-associated virus virions with variant capsid and methods of use thereof
#367Adeno-associated virus virions with variant capsid and methods of use thereof
#368Modified virus vectors and methods of making and using the same
#369Mutant adeno-associated virus virions and methods of use thereof
#370Recombinant AAV capsid protein
#371Capsid-modified rAAV vector compositions and methods therefor
#372CNS targeting AAV vectors and methods of use thereof
#373Class of therapeutic protein based molecules
#374AAV's and uses thereof
#375Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction
#376Adeno-associated virus virions with variant capsid and methods of use thereof
#377Adeno-associated virus virions with variant capsid and methods of use thereof
#378Polypeptides and vectors for targeting HER2/expressing cells and uses thereof
#379Capsid-modified rAAV vector compositions having improved transduction efficiencies, and methods of use
#380Encryption of adeno-associated viruses with enzymatically decoded peptide locks
#381Adeno-associated virus vector for gene transfer to nervous system cells
#382Use of microvesicles in the treatment of medical conditions
#383CNS targeting AAV vectors and methods of use thereof
#384Methods of increasing efficiency of vector penetration of target tissue
#385Mutated structural protein of a parvovirus
#386Compositions and Methods for Treating Diseases
#387Viral Vectors with Improved Properties
#388Methods and compositions related to adenoassociated virus-phage particles
#389Adeno-associated virus virions with variant capsid and methods of use thereof
#390AAV's and uses thereof
#391Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction
#392Compositions for targeting conducting airway cells comprising adeno-associated virus constructs
#393Modified virus vectors and methods of making and using the same
#394Class of therapeutic protein based molecules
#395TREATMENT OF NON-ALCOHOLIC STEATOTIC HEPATITIS (NASH)
#396Method for treating stroke via administration of NEP1-40 and inosine
#397AVV Vectors and Methods
#398Methods and compositions related to adenoassociated virus-phage particles
#399MUTATED STRUCTURAL PROTEIN OF A PARVOVIRUS
#400Isolation of novel AAV'S and uses thereof
#401METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASE
#402SCLEROPROTEIN OF AN ADENO-ASSOCIATED VIRUS WITH MODIFIED CHROMATOGRAPHIC PROPERTIES, THE PRODUCTION THEREOF AND USE OF THE SAME
#403Tyrosine-modified recombinant rAAV vector compositions and methods for use
#404Humanized Viral Vectors and Methods of Use Thereof
#405High Transgene Expression Of A Pseudotyped Adeno-Associated Virus Type
#406Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
#407METHODS FOR TARGETING MODIFIED RAAV VECTORS TO MAMMALIAN CELLS
#408SCLEROPROTEIN OF AN ADENO-ASSOCIATED VIRUS WITH MODIFIED CHROMATOGRAPHIC PROPERTIES, THE PRODUCTION THEREOF AND USE OF THE SAME
#409Compositions and methods for targeting of viral vectors
#410Mutant adeno-associated virus virions and methods of use thereof
#411Methods and compositions for treating brain diseases
#412rAAV EXPRESSION SYSTEMS AND COMPOSITIONS
#413rAAV Expression Systems and Methods of Use
#414VIRAL VECTOR-BASED GENE THERAPY METHODS AND COMPOSITIONS
#415SCLEROPROTEIN OF AN ADENO ASSOCIATED VIRUS WITH MODIFIED CHROMATOGRAPHIC PROPERTIES, THE PRODUCTION THEREOF AND USE OF THE SAME
#416Treatment of Non-Alcoholic Steatotic Hepatitis (Nash)
#417Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same
#418METHODS AND COMPOSITIONS RELATED TO ADENOASSOCIATED VIRUS-PHAGE PARTICLES
#419Heparin and heparan sulfate binding chimeric vectors
#420AAV vector for gene therapy
#421Improved rAAv vectors
#422Viral vectors with improved properties
#423Virus vectors and methods of making and administering the same
#424Virus vectors and methods of making and administering the same
#425Modified baculovirus expression system for production of pseudotyped rAAV vector
#426Vp2-modified raav vector compositions and uses therefor
#427Raav expression systems for genetic modification of specific capsid proteins
#428AAV vectors and methods
#429Methods and compositions for the treatment of neurological disease
#430Factor H variants for treatment of disease
#431Modified complex platform of adeno-associated virus with improved rate of expression of loaded genes and reduced genotoxicity